unPAD Study (Unclassified Antibody Deficiency Study)

Already > 3,200 level 1 + level 2 forms completed for the unPAD study

We thank everyone for this incredible result so far.

All of you who have not yet started your participation, please reconsider and join this very large cohort of hypogammaglobulinemia patients (unclassified PAD + CVID as controls).

Study on Hyper-immunoglobulin E syndrome (HIES) due to dominant-negative STAT3 mutations

Centres that have fully registered eligible patients in the ESID-registry, have already been contacted directly and asked for approval to use the documented data.

Data has been extracted from ESID-R and provided to the study team. Analysis pending (01/2024).

CHH-Study: Risk factors for mortality in cartilage-hair hypoplasia

Risk factors for mortality in cartilage-hair hypoplasia

Data has been extracted and provided to the study team. Analysis completed and manuscript submitted (12/2023)